telmisartan has been researched along with ng-nitroarginine methyl ester in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heinemann, A; Holzer, P; Peskar, BA; Wachter, CH | 1 |
| Heinemann, A; Horina, G; Pieber, D; Pieber, TR; Sandner-Kiesling, A | 1 |
| Black, S; Cassis, LA; Gibson, LL; Hahner, L; Osborne-Lawrence, S; Samols, D; Schwartz, R; Shaul, PW; Thomas, GD; Vongpatanasin, W | 1 |
| Ishimitsu, T; Matsuoka, H; Ono, H; Ono, Y; Takahashi, T | 1 |
| Kagota, S; Kunitomo, M; Nakamura, K; Nejime, N; Shinozuka, K; Tada, Y | 1 |
| Majumdar, A; Nirwane, A; Pawar, V | 1 |
6 other study(ies) available for telmisartan and ng-nitroarginine methyl ester
| Article | Year |
|---|---|
Dilatation by angiotensin II of the rat femoral arterial bed in vivo via pressure/flow-induced release of nitric oxide and prostaglandins.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Blood Pressure; Bosentan; Female; Femoral Artery; Hexamethonium; Indomethacin; NG-Nitroarginine Methyl Ester; Nitric Oxide; Prazosin; Propranolol; Prostaglandins; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Sulfonamides; Telmisartan; Vasodilation | 1997 |
Pressor and mesenteric arterial hyporesponsiveness to angiotensin II is an early event in haemorrhagic hypotension in anaesthetised rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arginine Vasopressin; Benzimidazoles; Benzoates; Blood Pressure; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Glyburide; Hemodynamics; Indomethacin; Male; Mesenteric Artery, Superior; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phenylephrine; Potassium Channels; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Regional Blood Flow; Shock, Hemorrhagic; Telmisartan; Time Factors; Vasoconstrictor Agents | 1999 |
C-reactive protein causes downregulation of vascular angiotensin subtype 2 receptors and systolic hypertension in mice.
Topics: Angiotensin II; Animals; Benzimidazoles; Benzoates; C-Reactive Protein; Down-Regulation; Hypertension; Male; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Systole; Telmisartan | 2007 |
Combination therapy with telmisartan and spironolactone alleviates L-NAME exacerbated nephrosclerosis with an increase in PPAR-gamma and decrease in TGF-beta(1).
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Disease Models, Animal; Drug Therapy, Combination; Hypertension, Malignant; Male; Mineralocorticoid Receptor Antagonists; Nephrosclerosis; NG-Nitroarginine Methyl Ester; PPAR gamma; Rats; Rats, Inbred SHR; RNA, Messenger; Spironolactone; Telmisartan; Transforming Growth Factor beta1 | 2007 |
Telmisartan provides protection against development of impaired vasodilation independently of metabolic effects in SHRSP.Z-Lepr(fa)/IzmDmcr rats with metabolic syndrome.
Topics: Acetylcholine; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood; Blood Glucose; Blood Pressure; Cholesterol; Crosses, Genetic; Guanylate Cyclase; Hypoglycemic Agents; Insulin; Male; Mesenteric Arteries; Metabolic Syndrome; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Nitroprusside; Phenylephrine; Pioglitazone; Rats; Rats, Inbred SHR; Rats, Zucker; Receptors, Cytoplasmic and Nuclear; Soluble Guanylyl Cyclase; Telmisartan; Thiazolidinediones; Triglycerides; Tyrosine; Vasoconstriction; Vasodilation | 2011 |
Therapeutic interventions using a combination of Telmisartan and omega 3-fatty acids in sodium arsenite-induced vascular endothelial dysfunction in rats: modulation through ATP-sensitive K+ channels and eNOS.
Topics: Animals; Aorta, Thoracic; Arsenites; Benzimidazoles; Benzoates; Cardiovascular Agents; Cholesterol; Endothelium, Vascular; Fatty Acids, Omega-3; Glyburide; KATP Channels; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Oxidative Stress; Rats, Wistar; Sodium Compounds; Telmisartan; Thiobarbituric Acid Reactive Substances; Triglycerides; Vascular Diseases; Vasodilation | 2015 |